154 related articles for article (PubMed ID: 30942404)
1. High expression of B7‑H2 or B7‑H3 is associated with poor prognosis in hepatocellular carcinoma.
Zheng Y; Liao N; Wu Y; Gao J; Li Z; Liu W; Wang Y; Li M; Li X; Chen L; Zhang W; Zhao B
Mol Med Rep; 2019 May; 19(5):4315-4325. PubMed ID: 30942404
[TBL] [Abstract][Full Text] [Related]
2. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.
Li YM; Liu ZY; Li ZC; Wang JC; Yu JM; Yang HJ; Chen ZN; Tang J
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609841
[TBL] [Abstract][Full Text] [Related]
4. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
5. B7‑H3 promotes malignant progression of muscle‑invasive bladder cancer.
Xu ZL; Zhang Y; Wang L; Li F; Man HW; Li PF; Shan BE
Oncol Rep; 2018 Nov; 40(5):2722-2733. PubMed ID: 30132557
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.
Liu H; Wu Q; Liu Y; Liu W; Zhang W; Pan D; Xu J
Jpn J Clin Oncol; 2015 Sep; 45(9):844-53. PubMed ID: 26056329
[TBL] [Abstract][Full Text] [Related]
7. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
8. Dual role of B7-H6 as a novel prognostic marker in hepatocellular carcinoma.
Qiu H; Gao S; Sun Z; Wang J
APMIS; 2021 Mar; 129(3):105-117. PubMed ID: 33220098
[TBL] [Abstract][Full Text] [Related]
9. B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence.
Sun TW; Gao Q; Qiu SJ; Zhou J; Wang XY; Yi Y; Shi JY; Xu YF; Shi YH; Song K; Xiao YS; Fan J
Cancer Immunol Immunother; 2012 Nov; 61(11):2171-82. PubMed ID: 22729558
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma: In Vivo Evaluation of Water Percentage as a Prognostic Biomarker Using Magnetic Resonance Imaging 3D-VIBE Multiecho Dixon.
Wang M; Yuan F; Wei Y; Xia C; Hu F; Song B
Cancer Biother Radiopharm; 2018 Sep; 33(7):300-306. PubMed ID: 30109954
[TBL] [Abstract][Full Text] [Related]
11. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
Wang F; Ying H; He B; Pan Y; Sun H; Wang S
Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of MTHFD1 in hepatocellular carcinoma predicts poorer survival and recurrence.
Yu H; Wang H; Xu HR; Zhang YC; Yu XB; Wu MC; Jin GZ; Cong WM
Future Oncol; 2019 May; 15(15):1771-1780. PubMed ID: 30997850
[No Abstract] [Full Text] [Related]
13. Decreased expression of PTPN12 correlates with tumor recurrence and poor survival of patients with hepatocellular carcinoma.
Luo RZ; Cai PQ; Li M; Fu J; Zhang ZY; Chen JW; Cao Y; Yun JP; Xie D; Cai MY
PLoS One; 2014; 9(1):e85592. PubMed ID: 24475046
[TBL] [Abstract][Full Text] [Related]
14. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
15. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
16. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
Liu M; Hu Q; Tu M; Wang X; Yang Z; Yang G; Luo R
J Exp Clin Cancer Res; 2018 Jan; 37(1):10. PubMed ID: 29357919
[TBL] [Abstract][Full Text] [Related]
17. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
[TBL] [Abstract][Full Text] [Related]
18. Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.
Tsuchiya K; Komuta M; Yasui Y; Tamaki N; Hosokawa T; Ueda K; Kuzuya T; Itakura J; Nakanishi H; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Sakamoto M; Izumi N
Oncology; 2011; 80(3-4):278-88. PubMed ID: 21734420
[TBL] [Abstract][Full Text] [Related]
19. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
[TBL] [Abstract][Full Text] [Related]
20. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
